The impact of platelet function inhibition on circulating cancer cells in metastatic breast cancer patients.
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 24 Jan 2017 Status changed from completed to discontinued due to low percentage of patients with detectable CTCs at baseline.
- 18 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History